"Myocardial work could be a new
echocardiographic tool for
early identification of heart
function abnormalities in
patients with long COVID-19."
Researchers used spirometry and chest computed tomography (CT) to assess participants’ lung function and possible COVID-19 sequelae 1 year after hospital discharge. Investigators performed transthoracic echocardiography (TTE) and used a new echocardiography-based imaging technique called myocardial work to noninvasively determine total active myocardial performance, providing more precise information on cardiac function than previous methods.
At 1 year after hospital discharge, 23 patients (34.8%) had dyspnea during physical activity, according to the study abstract.
Researchers found that abnormal heart function was independently and significantly associated with persistent exertional dyspnea at 1-year post-discharge, after the team adjusted for age and gender. Furthermore, cardiac imaging showed poorer cardiac performance in participants with dyspnea than without dyspnea at 1 year after hospitalization.
“Myocardial work could be a new echocardiographic tool for early identification of heart function abnormalities in patients with long COVID-19, who might need more frequent and long-term cardiac surveillance,” concluded Luchian in the release. “Future studies including different COVID-19 variants and the impact of vaccination are needed to confirm our results on the long-term evolution and possible cardiac consequences of this disease.”
Reference: Luchian ML, Lochy S, Belsack D, et al. Persistent dyspnea 1 year after COVID - 19 infection in apparently healthy subjects: a potential indicator of subclinical cardiac dysfunction. Abstract presented at EuroEcho 2021, held virtually December 9-11, 2021.